- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Evolent Health Inc (EVH)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/26/2025: EVH (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $10.18
1 Year Target Price $10.18
| 9 | Strong Buy |
| 4 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.69% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 477.80M USD | Price to earnings Ratio - | 1Y Target Price 10.18 |
Price to earnings Ratio - | 1Y Target Price 10.18 | ||
Volume (30-day avg) 14 | Beta 0.27 | 52 Weeks Range 3.50 - 12.98 | Updated Date 12/28/2025 |
52 Weeks Range 3.50 - 12.98 | Updated Date 12/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.58 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.24% | Operating Margin (TTM) 0.14% |
Management Effectiveness
Return on Assets (TTM) 0.12% | Return on Equity (TTM) -12.4% |
Valuation
Trailing PE - | Forward PE 20.62 | Enterprise Value 1425460526 | Price to Sales(TTM) 0.23 |
Enterprise Value 1425460526 | Price to Sales(TTM) 0.23 | ||
Enterprise Value to Revenue 0.69 | Enterprise Value to EBITDA 92.39 | Shares Outstanding 111600856 | Shares Floating 86431515 |
Shares Outstanding 111600856 | Shares Floating 86431515 | ||
Percent Insiders 1.64 | Percent Institutions 124.09 |
Upturn AI SWOT
Evolent Health Inc

Company Overview
History and Background
Evolent Health, Inc. was founded in 2011 by the merger of Renaissance Health Service Corporation and Union Health Services. The company aims to partner with healthcare providers and health plans to deliver value-based care. Key milestones include its IPO in 2015 and subsequent acquisitions to expand its capabilities in areas like population health management and data analytics.
Core Business Areas
- Evolent Health's Platform: Evolent Health offers a comprehensive technology and services platform designed to support value-based care models. This includes solutions for population health management, care management, and revenue cycle management, enabling providers and payers to improve patient outcomes and control costs.
- Provider Solutions: This segment focuses on empowering healthcare providers to succeed in value-based care arrangements. Services include clinical operations support, advanced analytics, and performance improvement tools to manage patient populations and financial risk.
- Payer Solutions: Evolent provides health plans with capabilities to manage their members effectively under value-based contracts. This includes member engagement tools, risk adjustment services, and data analytics to optimize plan performance and member satisfaction.
Leadership and Structure
Evolent Health is led by a management team with extensive experience in healthcare and technology. The organizational structure is typically segmented by business lines and customer types (providers and payers) to ensure focused service delivery. Key leadership roles include CEO, CFO, and heads of various operational and strategic divisions.
Top Products and Market Share
Key Offerings
- Evolent Health Platform: A comprehensive suite of technology and services enabling value-based care. This platform integrates data, streamlines workflows, and supports care coordination. Specific modules include population health management, care management, and analytics. Competitors include Optum, Cerner (now Oracle Health), and other health IT vendors offering similar integrated solutions. Market share data for specific products is not readily available, but Evolent serves a significant number of provider and payer organizations.
- Provider Solutions Suite: Tools and services tailored for healthcare providers to manage performance in value-based payment models. This includes clinical workflow optimization and performance benchmarking. Competitors include companies specializing in practice management and clinical analytics. Evolent's strength lies in its integrated approach for value-based care.
- Payer Solutions Suite: Services designed to help health plans manage member populations and financial risk under value-based contracts. This encompasses member outreach, data analysis, and financial reconciliation. Competitors include large health insurance technology providers and consulting firms. Evolent differentiates itself by its focus on driving value-based outcomes.
Market Dynamics
Industry Overview
The healthcare industry is undergoing a significant shift from fee-for-service to value-based care, driven by the need to control costs and improve patient outcomes. This trend is fueled by technological advancements, increasing healthcare expenditure, and regulatory initiatives promoting alternative payment models. The market for population health management and care coordination solutions is growing rapidly.
Positioning
Evolent Health is positioned as a partner for providers and health plans navigating the complexities of value-based care. Its key competitive advantages include its integrated technology and services platform, deep expertise in value-based care models, and a focus on delivering measurable results in terms of improved patient care and cost reduction.
Total Addressable Market (TAM)
The Total Addressable Market (TAM) for healthcare IT and services supporting value-based care is substantial and growing, estimated in the hundreds of billions of dollars globally. Evolent Health is positioned to capture a significant share of this market by focusing on provider and payer organizations transitioning to or optimizing value-based care strategies.
Upturn SWOT Analysis
Strengths
- Integrated technology and services platform
- Deep expertise in value-based care models
- Strong relationships with provider and payer clients
- Focus on measurable outcomes and ROI
- Scalable business model
Weaknesses
- Reliance on long-term client contracts
- Intense competition in the healthcare IT market
- Potential challenges in integrating acquired technologies
- Need for continuous innovation to keep pace with industry changes
Opportunities
- Continued growth of value-based care models
- Expansion into new market segments and geographies
- Leveraging data analytics for advanced insights
- Partnerships with other healthcare technology providers
- Increasing demand for population health management solutions
Threats
- Changes in healthcare policy and regulations
- Emergence of disruptive technologies
- Economic downturns impacting healthcare spending
- Cybersecurity risks and data breaches
- Intensified competition from larger players
Competitors and Market Share
Key Competitors
- Optum (part of UnitedHealth Group) (UNH)
- Cerner Corporation (now Oracle Health) (ORCL)
- Allscripts Healthcare Solutions (now Veradigm) (VRDM)
- Change Healthcare (now part of Optum)
- Philips Healthcare
- IBM Watson Health (now Francisco Partners)
Competitive Landscape
Evolent Health competes in a dynamic and fragmented market. Its advantages lie in its specialized focus on value-based care and its integrated platform. However, it faces strong competition from larger, diversified healthcare IT companies with broader service portfolios and extensive market reach. Evolent's ability to innovate and demonstrate clear ROI for its clients will be critical to maintaining its competitive edge.
Major Acquisitions
Sy true
- Year: 2021
- Acquisition Price (USD millions): 247
- Strategic Rationale: To enhance Evolent Health's capabilities in data analytics and population health management, particularly for behavioral health and substance use disorder populations, and to expand its client base.
e4 Health
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: To strengthen Evolent Health's payer solutions, particularly in the area of chronic care management and supporting payers in value-based care models.
Growth Trajectory and Initiatives
Historical Growth: Evolent Health has experienced significant historical growth since its inception, driven by its expansion into the value-based care market and strategic acquisitions. This growth has been characterized by increasing revenue and a broadening client base.
Future Projections: Future growth is projected to be fueled by the ongoing shift towards value-based care, which expands the market for Evolent's solutions. Analyst estimates typically forecast continued revenue growth, driven by new client wins, expansion of services to existing clients, and potential strategic partnerships or acquisitions.
Recent Initiatives: Recent initiatives have likely focused on enhancing its technology platform, expanding its data analytics capabilities, and strengthening its service offerings to address evolving healthcare needs. This could include investments in AI and machine learning for better predictive analytics and patient engagement.
Summary
Evolent Health Inc. is a key player in the rapidly evolving value-based care landscape, offering a robust technology and services platform. Its strengths lie in its specialized expertise and integrated solutions, positioning it well to capitalize on the industry's shift. However, it faces intense competition and requires continuous innovation to maintain its competitive edge. Future growth depends on its ability to expand its client base and deepen its service offerings.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Evolent Health Inc. Investor Relations
- SEC Filings (10-K, 10-Q)
- Industry Analyst Reports
- Financial News Outlets (e.g., Bloomberg, Reuters)
Disclaimers:
This JSON output is generated for informational purposes only and should not be considered as financial advice. Data accuracy and completeness are dependent on the availability and reliability of public sources. Market share percentages are illustrative and based on general industry understanding. Specific financial figures and projections should be verified with official company reports and professional financial advisors.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Evolent Health Inc
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4500 | Website https://www.evolent.com |
Full time employees 4500 | Website https://www.evolent.com | ||
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

